FDA-approved psychiatric drugs may help improve cognitive symptoms
University of Colorado Anschutz Medical Campus - 29-Jun-2022Imipramine or olanzapine block APOE4 and reverses Alzheimer’s disease
Join the club for FREE to access the whole archive and other member benefits.
Professor of neurology and director of the CU Alzheimer’s and Cognition Center
Huntington Potter is Professor of Neurology, Vice Chair of Basic Research in Neurology Department, Director of Alzheimer's Disease Program at the Linda Crnic Institute for Down Syndrome, and Director at University of Colorado Alzheimer's and Cognition Center.
Previously, Potter directed the Florida Alzheimer's Disease Research Center and the Johnnie B. Byrd Sr. Alzheimer's Center & Research Institute. He is currently expanding his discovery that Alzheimer's disease is mechanistically related to Down syndrome, which invariably leads to Alzheimer's by age 30-40.
Potter holds a PhD from Harvard Univeristy.
Visit website: https://medschool.cuanschutz.edu/alzheimer/about/directory/faculty/huntington-potter
See also: University of Colorado Anschutz Medical Campus - World-class medical destination at the forefront of transformative education, science, medicine and healthcare
Details last updated 10-Jul-2022
Imipramine or olanzapine block APOE4 and reverses Alzheimer’s disease